Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Volunteers · Hepatic Steatosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Parexel Research Unit, Harrow, United Kingdom

Study leads

Clinical Transparency (dept. 2834)
Study Director
Novo Nordisk A/S

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients

Epilepsy · Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Tucson, United States · DeLand, United States

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

A Phase 1 Study of CLYM116 in Normal Healthy Volunteers

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Grayslake, United States